查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1993855

GMP生物製品市场：依产品类型、应用、服务、生产规模、最终用户、国家及地区划分－全球产业分析、市场规模、市场占有率及2025年至2032年预测

GMP Biologics Market, By Product Type, By Application, By Service, By Manufacturing Scale, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年 GMP 生物製药市场价值 678.1087 亿美元，预计从 2025 年到 2032 年将以 15.98% 的复合年增长率增长。

GMP生物製品是指依照良好生产规范（GMP）大规模生产的生物製药，GMP获得国内外监管机构的认可，以确保其品质、安全性和有效性的一致性。生物製品是源自活细胞的联合疗法，包括单株抗体、疫苗、重组蛋白以及先进的细胞和基因疗法。由于其结构脆弱且生产流程复杂，从原材料采购到最终包装的每个环节都需要严格的法律规范。

从全球管治的角度来看，世界卫生组织（WHO）等组织提供国际认可的药品生产品质管理规范（GMP）指南，这些指南已被100多个国家采纳，旨在协调药品品质标准。同时，包括美国食品药物管理局（FDA）和欧洲药品管理局（EMA）在内的监管机构报告称，近年来生物製药和生物类似药的核准数量稳步增长，这反映出先进治疗方法在应对癌症、自体免疫疾病和罕见疾病方面发挥着越来越重要的作用。公共卫生数据显示，生物製药目前在主要市场新核准的疗法中占相当大的比例，这凸显了高品质生物製药能力的提升以及各国政府对确保全球药品供应链韧性的高度重视。

GMP生物製药市场－市场动态

对先进生物製药疗法的需求日益增长，以支持长期医疗保健的永续性。

在医疗保健系统中，针对慢性病和复杂疾病的生物製药疗法正日益受到重视，因为人们期望这些疗法能够改善治疗效果并减轻长期治疗负担。这种向精准医疗的转变正在加速对高品质GMP认证生产基础设施的需求，从而促进市场稳步扩张。随着癌症和自体免疫疾病等慢性病在全球疾病负担中所占比例的不断上升，世界各国政府都在优先发展生物製药，以减少住院时间和降低系统性成本。例如，印度政府已在其2026-2027财年联邦预算中拨款12亿美元，推出「生物製药SHAKTI」倡议，该计划旨在打造一个全球生物製药和生物类似药的製造地。同样，辉瑞和礼来等大型公司正在扩大其符合GMP标准的生产能力以满足这一需求，预计到2026年，全球生物製药市场规模将超过5,340亿美元。透过确保标靶治疗的可扩展生产，GMP生物製药产业为建立一个具有韧性、以价值为导向的全球医疗保健生态系统提供了必要的基础设施。

GMP生物製品市场－市场区隔分析：

全球GMP生物製品市场按产品类型、应用、服务、生产规模、最终用户和地区进行细分。

根据产品类型，全球市场可分为四大类：单株抗体（mAb）、重组蛋白、疫苗、细胞和基因疗法。单株抗体被广泛认为是未来全球生物製药市场最重要的细分领域。由于单株抗体在治疗癌症和自体免疫疾病等重大慢性复杂疾病方面疗效显着，且与许多传统治疗方法相比副作用更少，并能精准靶向疾病通路，因此已占据全球生物製药销售额的最大份额。事实上，近年来美国食品药物管理局（FDA）核准了大量单株抗体疗法，其临床重要性日益凸显，预计2024年单株抗体核准数量将创下历史新高。罗氏、艾伯维和辉瑞等领先的生物製药公司已建构了强大的单株抗体产品组合，并持续扩大符合GMP标准的产能，以满足全球需求。Herceptin（罗氏）和阿达木单抗（艾伯维）等重磅疗法正在推动持续的商业性成功和广泛应用。

依生产规模，生物製剂市场可分为三类：临床规模、商业规模及中试规模。预计全球GMP生物製剂市场中，商业规模生产将显着成长。这是因为商业规模生产能够在核准的生物製剂疗法完成临床开发阶段后，实现大规模、稳定的生产，这对于满足全球对单株抗体、疫苗和基因疗法等治疗方法的需求至关重要，并有助于惠及更广泛的患者群体。像三星生物製剂这样的领先生产企业，已建成多个产能超过数十万公升的大规模GMP工厂，并正积极扩大其商业生产基地，以履行与辉瑞等主要製药合作伙伴的长期供应合约。同时，美国食品药物管理局（FDA）等监管机构维持严格的GMP标准和核准要求，支持从小小规模和临床生产向全面商业化生物製药供应的过渡，进一步强化了商业生产基础设施在确保全球可靠、高品质生物製药供应方面的核心作用。

GMP生物製药市场—区域洞察

从地理角度来看，北美预计将继续保持其作为GMP生物製药生产和创新中心的重要地位，这得益于其先进的监管基础设施和强大的公共卫生投资。在美国，食品药物管理局（FDA）严格监管良好生产规范（GMP）的执行情况，以确保高品质生物製药的生产，并已核准数百种生物製药用于治疗用途。美国拥有庞大的国内需求和工业产能，是全球最大的生物製药生产基地之一，并在单株抗体、疫苗和重组蛋白领域拥有强大的开发平臺。加拿大也为该地区的优势做出了贡献，生物製药在其国内药品支出中占有相当大的比例，这表明生物治疗药物正在不断融入其医疗保健体系。

从行业角度来看，领先的製药和生物技术公司正在北美扩大其生物製药生产能力，以服务国内和出口市场。安进和辉瑞等创新美国公司经营符合GMP标准的大规模生产设施，并持续投资下一代生物製药生产技术。这些公司正与联邦机构密切合作，在遵守不断发展的品质标准的同时，提高生产效率。在加拿大，国家监管指南鼓励遵守国际GMP标准，从而促进了跨境製药活动。整体而言，北美的监管保障、医疗保健需求和企业投资支撑着该地区在全球GMP生物製药市场中的重要地位。

中国GMP生物製药市场－各国概况

在积极的政府政策和国内产业能力提升的推动下，中国在生物製药製造领域扮演日益重要的角色。 2024年底，国家药品监督管理局推出了分阶段生物製药生产试验计画。该专案允许生产企业专注于生物製药生产的不同阶段，从而提高生产效率并确保符合GMP标准。药明生物和中国医药集团等主要企业正为中国生物製药生产做出重大贡献，其产品涵盖疫苗、抗体医药品和复杂治疗性蛋白质等。这些发展体现了中国致力于强化製造业生态系统、提升监管完整性和支持创新，以满足国内医疗需求并掌握不断扩大的出口机会的战略重点。

目录

第一章：GMP生物製品市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：GMP生物製品市场的主要趋势

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 未来市场趋势

第四章：GMP生物製品产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长前景展望图
  • 管理体制分析

第五章：GMP生物製品市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：GMP生物製品市场趋势

  • GMP生物製品市占率分析，2024年
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 GMP生物製品市场：依产品类型划分

  • 概述
    • 基于细分市场的市场份额分析：按产品类型
    • 单株抗体（mAbs）
    • 重组蛋白
    • 疫苗
    • 细胞和基因治疗

第八章 GMP生物製品市场：依应用划分

  • 概述
    • 基于细分市场的市场份额分析：按应用领域
    • 肿瘤学
    • 免疫学
    • 感染疾病
    • 罕见疾病
    • 心血管疾病

第九章 GMP生物製品市场：依服务分类

  • 概述
    • 基于细分市场的市占率分析：按服务
    • 製程开发
    • 分析测试服务
    • 灌装和包装服务
    • 上游工程
    • 下游加工

第十章 GMP生物製品市场：依生产规模划分

  • 概述
    • 基于细分市场的市场份额分析：按应用领域
    • 临床量表
    • 商业规模
    • 中试规模

第十一章 GMP生物製品市场：依最终用户划分

  • 概述
    • 生物製药公司
    • 合约研发生产组织（CDMO）
    • 研究机构
    • 临床研究机构（CRO）

第十二章 GMP生物製品市场：按地区划分

  • 介绍
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商：欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 概述
    • 主要製造商：亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他亚太国家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 概述
    • 主要生产商：中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他中东和非洲国家

第十三章：主要供应商分析：GMP生物製品产业

  • 竞争基准
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
    • Samsung Biologics
    • WuXi Biologics
    • Amgen Inc.
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis AG
    • Merck & Co.
    • Bristol Myers Squibb
    • Sanofi
    • Lonza Group
    • Catalent Inc.
    • Thermo Fisher Scientific
    • Cobra Biologics
    • AstraZeneca plc
    • Charles River Laboratories International, Inc.
    • Rentschler Biopharma SE
    • Others

第十四章：AnalystView 的全景视图

简介目录
Product Code: ANV6158

GMP Biologics Market size was valued at US$ 67,810.87 Million in 2024, expanding at a CAGR of 15.98% from 2025 to 2032.

GMP Biologics refers to biological medicines that are mass-produced in compliance with Good Manufacturing Practice (GMP) standards recognized by national and international regulatory authorities to ensure consistent quality, safety, and effectiveness. Biologics are compound therapies derived from living cells and include monoclonal antibodies, vaccines, recombinant proteins, and advanced cell and gene therapies. Due to their structural sensitivity and sophisticated production processes, strict regulatory oversight is required at every stage from raw material sourcing to final packaging.

From a global governance view, institutions such as the World Health Organization provide internationally recognized GMP guidelines adopted by more than 100 countries to harmonize pharmaceutical quality standards. In parallel, regulatory authorities, including the U.S. Food and Drug Administration and the European Medicines Agency (EMA), have reported a consistent rise in biologics and biosimilar approvals over recent years, reflecting the growing role of advanced therapies in addressing cancer, autoimmune disorders, and rare diseases. Public health data further specify that biologic products now represent a significant share of newly approved therapeutic agents in major markets, underscoring strong governmental emphasis on expanding high-quality biomanufacturing capacity and ensuring resilient pharmaceutical supply chains worldwide.

GMP Biologics Market- Market Dynamics

Rising demand for advanced biologic therapies to support long-term healthcare sustainability

Healthcare systems are increasingly prioritizing targeted biologic treatments for chronic and complex diseases due to their potential to improve outcomes and reduce long-term treatment burden. This shift toward precision medicine is accelerating the need for high-quality GMP-certified production infrastructure, contributing to steady market expansion. As chronic conditions like cancer and autoimmune disorders increasingly dominate the global disease burden, governments are prioritizing biologics to reduce long-term hospitalizations and systemic costs. For instance, the Government of India, in its Union Budget 2026-27, launched the "Biopharma SHAKTI" initiative with an outlay of $1.2 billion to establish a global manufacturing hub for biologics and biosimilars. Similarly, corporate leaders like Pfizer and Eli Lilly are scaling GMP-compliant production to meet this need, with the global biologics market projected to exceed $534 billion by 2026. By ensuring the scalable production of targeted therapies, the GMP biologics sector provides the essential infrastructure for a resilient, value-based global healthcare ecosystem.

GMP Biologics Market- Segmentation Analysis:

The Global GMP Biologics Market is segmented on the basis of Product Type, Application, Service, Manufacturing Scale, End User, and Region.

On the basis of product type global market is divided into four categories: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies. Monoclonal Antibodies are widely acknowledged as the segment set to play the most pivotal role in the global biologics market in the near term. mAbs already account for the largest share of biologics revenue globally due to their proven effectiveness in treating major chronic and complex diseases such as cancer and autoimmune disorders, and their ability to target disease pathways with precision and fewer side effects than many traditional therapies. In fact, the U.S. Food and Drug Administration (FDA) approved a notably high number of monoclonal antibody therapies in recent years, including a record number of mAb approvals in 2024, reinforcing their clinical importance. Major biopharmaceutical players such as Roche, AbbVie, and Pfizer have built robust monoclonal antibody portfolios and continue to expand GMP-compliant production capacity to meet global demand, with blockbuster therapies like Herceptin (Roche) and Humira (AbbVie) driving sustained commercial performance and uptake.

The market is divided into three categories based on manufacturing scale: Clinical Scale, Commercial Scale, and Pilot Scale. Commercial-scale manufacturing is forecasted to register meaningful growth in the GMP biologics market at a global level because it enables the large volume, consistent production of approved biologic therapies once they clear clinical development, which is essential to meet worldwide demand for treatments such as monoclonal antibodies, vaccines, and gene-based therapies and to support broad patient access. Leading manufacturing specialists like Samsung Biologics, which has built multiple large capacity GMP plants exceeding hundreds of thousands of liters, are actively expanding their commercial production footprint to serve long term supply contracts with major pharmaceutical partners such as Pfizer and others. At the same time, regulators like the U.S. Food and Drug Administration (FDA) maintain stringent GMP expectations and approvals that underpin the transition from small-scale and clinical production to full-scale commercial biologics supply, reinforcing the central role of commercial manufacturing infrastructure in ensuring reliable, high-quality biologic availability worldwide.

GMP Biologics Market- Geographical Insights

From the geographical point of view shows that North America is expected to remains a influential hub for GMP biologics manufacturing and innovation, supported by advanced regulatory infrastructure and strong public health investment. In the United States, the U.S. Food and Drug Administration oversees stringent good manufacturing practice (GMP) compliance, ensuring high-quality biologics production, and has approved hundreds of biologic products for therapeutic use. The U.S. benefits from one of the largest concentrations of biologics manufacturing facilities and a robust pipeline of monoclonal antibodies, vaccines, and recombinant proteins, reflecting broad domestic demand and industry capability. Canada also contributes to regional strength, with biologics accounting for a significant share of national pharmaceutical expenditure, indicating sustained integration of biotherapeutic products within healthcare systems.

From an industry perception, leading pharmaceutical and biotech companies are expanding their biologics manufacturing capacity in North America to serve both domestic and export markets. U.S.-based innovators like Amgen and Pfizer operate large GMP-compliant facilities and continue to invest in next-generation biologic production technologies. These firms work closely with federal agencies to adhere to evolving quality standards while advancing production efficiency. In Canada, national regulatory guidance encourages alignment with international GMP standards, supporting cross-border pharmaceutical activities. Collectively, North America's regulatory assurance, healthcare demand, and corporate investment underpin its influential role in the global GMP biologics landscape.

China GMP Biologics Market- Country Insights

China has become an increasingly important player in biologics manufacturing, driven by proactive government policies and growing domestic industry capabilities. The National Medical Products Administration introduced a pilot program for segmented production of biological products in late 2024, enabling facilities to specialize in different stages of biologics manufacturing to improve efficiency and support compliance with GMP standards. Major Chinese firms such as WuXi Biologics and state-owned China National Pharmaceutical Group Corporation contribute significantly to the country's biologics output, including vaccines, antibody drugs, and complex therapeutic proteins. These developments reflect China's strategic focus on strengthening its manufacturing ecosystem, enhancing regulatory alignment, and supporting innovation to meet both domestic healthcare needs and expanding export opportunities.

GMP Biologics Market- Competitive Landscape:

Driven by the growing demand for advanced therapeutics and biologic treatments, the global GMP biologics market comprises both multinational pharmaceutical companies and regional manufacturers, making it a highly competitive sector. Companies distribute biologics through contract manufacturing, direct partnerships with healthcare providers, and specialized biopharmaceutical channels. Market participants compete on factors such as production quality, compliance with GMP standards, technological capabilities, cost efficiency, and regulatory alignment. Key strategies to strengthen market presence include expanding production capabilities, enhancing research and development initiatives, forming strategic partnerships, and pursuing targeted acquisitions. For example, WuXi Biologics and Samsung Biologics continue to strengthen global reach through advanced manufacturing facilities and strategic partnerships.

Recent Developments:

In December 2025, Samsung Biologics announced it would acquire its first U.S. drug production facility from GlaxoSmithKline for about $280 million, enabling expanded biologics production capacity in the United States and strengthening its long term manufacturing footprint.

In April 2025, WuXi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign at a new 15,000L production line at its Hangzhou site. This milestone marks the successful scaling of one of Asia's largest single-use bioreactor systems, enhancing the company's commercial manufacturing capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Samsung Biologics
  • WuXi Biologics
  • Amgen Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Merck & Co.
  • Bristol Myers Squibb
  • Sanofi
  • Lonza Group
  • Catalent Inc.
  • Thermo Fisher Scientific
  • Cobra Biologics
  • AstraZeneca plc
  • Charles River Laboratories International, Inc.
  • Rentschler Biopharma SE
  • Others

GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies

GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Immunology
  • Infectious Diseases
  • Rare Diseases
  • Cardiovascular Diseases

GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Process Development
  • Analytical Testing Service
  • Fill-Finish Service
  • Upstream Manufacturing
  • Downstream Processing

GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Scale
  • Commercial Scale
  • Pilot Scale

GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Research Institutes
  • Clinical Research Organizations (CROs)

GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. GMP Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. GMP Biologics Market Snippet by Product Type
    • 2.1.2. GMP Biologics Market Snippet by Application
    • 2.1.3. GMP Biologics Market Snippet by Service
    • 2.1.4. GMP Biologics Market Snippet by Manufacturing Scale
    • 2.1.5. GMP Biologics Market Snippet by End User
    • 2.1.6. GMP Biologics Market Snippet by Country
    • 2.1.7. GMP Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. GMP Biologics Key Market Trends

  • 3.1. GMP Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. GMP Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. GMP Biologics Market Opportunities
  • 3.4. GMP Biologics Market Future Trends

4. GMP Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GMP Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. GMP Biologics Market Landscape

  • 6.1. GMP Biologics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. GMP Biologics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Monoclonal Antibodies (mAbs)
    • 7.1.3. Recombinant Proteins
    • 7.1.4. Vaccines
    • 7.1.5. Cell & Gene Therapies

8. GMP Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Infectious Diseases
    • 8.1.5. Rare Diseases
    • 8.1.6. Cardiovascular Diseases

9. GMP Biologics Market - By Service

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service, 2024 & 2032 (%)
    • 9.1.2. Process Development
    • 9.1.3. Analytical Testing Services
    • 9.1.4. Fill-Finish Services
    • 9.1.5. Upstream Manufacturing
    • 9.1.6. Downstream Processing

10. GMP Biologics Market - By Manufacturing Scale

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical Scale
    • 10.1.3. Commercial Scale
    • 10.1.4. Pilot Scale

11. GMP Biologics Market - By End User

  • 11.1. Overview
    • 11.1.1. Biopharmaceutical Companies
    • 11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
    • 11.1.3. Research Institutes
    • 11.1.4. Clinical Research Organizations (CROs)

12. GMP Biologics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. GMP Biologics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. GMP Biologics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. GMP Biologics Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. GMP Biologics Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. GMP Biologics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- GMP Biologics Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Samsung Biologics
    • 13.2.2. WuXi Biologics
    • 13.2.3. Amgen Inc.
    • 13.2.4. Pfizer Inc.
    • 13.2.5. Roche Holding AG
    • 13.2.6. Novartis AG
    • 13.2.7. Merck & Co.
    • 13.2.8. Bristol Myers Squibb
    • 13.2.9. Sanofi
    • 13.2.10. Lonza Group
    • 13.2.11. Catalent Inc.
    • 13.2.12. Thermo Fisher Scientific
    • 13.2.13. Cobra Biologics
    • 13.2.14. AstraZeneca plc
    • 13.2.15. Charles River Laboratories International, Inc.
    • 13.2.16. Rentschler Biopharma SE
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us